Eupraxia Pharmaceuticals has disclosed additional positive data from its Phase Ib/IIa RESOLVE clinical trial of EP-104GI in treating eosinophilic esophagitis (EoE). The multicentre, open-label, ...

A condition known as eosinophilic esophagitis, or EoE, affects one in 1,500 kids. They actually have an allergic reaction ...

For patients with severe asthma with an eosinophilic phenotype, depemokimab reduces the annualized rate of exacerbations, ...

There is moderate to abundant eosinophilic cytoplasm (×20 ... Neuroendocrine markers (d) synaptophysin and (e) chromogranin are positive in tumor cells (×20), and (f) proliferation labeling index with ...

Study reviews transplant-acquired food allergies, focusing on pediatric patients, particularly liver transplant recipients.

AstraZeneca’s FASENRA ® (benralizumab) has been approved in the US for the treatment of adult patients with eosinophilic granulomatosis with polyangiitis (EGPA). 1 EGPA is a rare, immune-mediated ...

The partnership will see the application of AI-enabled screening to address bioavailability issues with Equillium’s ...

Degenerated urothelial cells present with shrunken (condensed), dark nuclei with mildly irregular nuclear borders, granular cytoplasm, and eosinophilic and/or cyanophilic intracytoplasmic inclusions ...

Vivtex to apply its GI-ORIS™ technology to optimize oral bioavailability of EQ302, Equillium’s novel IL-15/IL-21 bi-specific peptide ...

Confirming the results of Study A, this second pivotal trial in biologic-naïve patients met primary and key secondary endpoints, showing ...

Dupixent phase 3 study confirms significant improvements in itch and hives for patients with CSU: Paris Thursday, September 12, 2024, 13:00 Hrs [IST] A Dupixent (dupilumab) confir ...